These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 24999371
1. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids. Desjardins M, Xie J, Gurler H, Muralidhar GG, Sacks JD, Burdette JE, Barbolina MV. J Ovarian Res; 2014; 7():70. PubMed ID: 24999371 [Abstract] [Full Text] [Related]
8. P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions. Usui A, Ko SY, Barengo N, Naora H. Mol Cancer Res; 2014 Apr; 12(4):504-13. PubMed ID: 24448686 [Abstract] [Full Text] [Related]
9. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids. He M, Wang D, Zou D, Wang C, Lopes-Bastos B, Jiang WG, Chester J, Zhou Q, Cai J. Oncotarget; 2016 Dec 27; 7(52):86374-86387. PubMed ID: 27863439 [Abstract] [Full Text] [Related]
10. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Correa RJ, Peart T, Valdes YR, DiMattia GE, Shepherd TG. Carcinogenesis; 2012 Jan 27; 33(1):49-58. PubMed ID: 22045027 [Abstract] [Full Text] [Related]
14. Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells. Kim M, Rooper L, Xie J, Kajdacsy-Balla AA, Barbolina MV. Mol Cancer Res; 2012 Jan 27; 10(1):11-24. PubMed ID: 22064656 [Abstract] [Full Text] [Related]
15. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention. Zheng N, Chen J, Li T, Liu W, Liu J, Chen H, Wang J, Jia L. Mol Carcinog; 2017 Aug 27; 56(8):1896-1908. PubMed ID: 28277622 [Abstract] [Full Text] [Related]
16. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids. Ziske MA, Pettee KM, Khaing M, Rubinic K, Eisenmann KM. Biochem Biophys Res Commun; 2016 Mar 25; 472(1):33-9. PubMed ID: 26898799 [Abstract] [Full Text] [Related]
17. Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesothelium. Stadlmann S, Feichtinger H, Mikuz G, Marth C, Zeimet AG, Herold M, Knabbe C, Offner FA. Int J Gynecol Cancer; 2014 Feb 25; 24(2):192-200. PubMed ID: 24407573 [Abstract] [Full Text] [Related]
18. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F. Int J Cancer; 2008 Jan 01; 122(1):91-9. PubMed ID: 17893878 [Abstract] [Full Text] [Related]
19. Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins. Laurent-Issartel C, Landras A, Agniel R, Giffard F, Blanc-Fournier C, Da Silva Cruz E, Habes C, Leroy-Dudal J, Carreiras F, Kellouche S. Exp Cell Res; 2024 Aug 01; 441(1):114155. PubMed ID: 39002689 [Abstract] [Full Text] [Related]
20. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Ween MP, Hummitzsch K, Rodgers RJ, Oehler MK, Ricciardelli C. Clin Exp Metastasis; 2011 Feb 01; 28(2):113-25. PubMed ID: 21153687 [Abstract] [Full Text] [Related] Page: [Next] [New Search]